Lanzhou Foci Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Lanzhou Foci Pharmaceutical Co Ltd cash flow reinvestment rate. Lanzhou Foci Pharmaceutical Co Ltd (002644) has a Cash Flow Reinvestment Rate of 0.02x as of September 2025, reinvesting CN¥1.38 Million (capex CN¥1.38 Million ) from operating cash flow of CN¥75.62 Million. Explore how well can Lanzhou Foci Pharmaceutical Co Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Lanzhou Foci Pharmaceutical Co Ltd (2007–2024)
Cash flow reinvestment rate of Lanzhou Foci Pharmaceutical Co Ltd from 2007 to 2024. Historical reinvestment intensity for Lanzhou Foci Pharmaceutical Co Ltd across 16 annual periods. Explore 002644 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Lanzhou Foci Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2007–2024)
Lanzhou Foci Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2007 to 2024. Year-by-year capital reinvestment analysis for Lanzhou Foci Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Lanzhou Foci Pharmaceutical Co Ltd (002644) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.38x | CN¥14.84 Million | CN¥38.98 Million | CN¥13.29 Million | ▲ +2.2% |
| 2023 | 0.37x | CN¥24.47 Million | CN¥65.71 Million | CN¥22.47 Million | ▼ -68.1% |
| 2022 | 1.17x | CN¥84.36 Million | CN¥72.37 Million | CN¥41.51 Million | ▼ -78.8% |
| 2021 | 5.51x | CN¥65.29 Million | CN¥11.85 Million | CN¥32.81 Million | ▲ +122.7% |
| 2020 | 2.47x | CN¥155.51 Million | CN¥62.89 Million | CN¥122.58 Million | ▼ -12.8% |
| 2019 | 2.84x | CN¥135.65 Million | CN¥47.82 Million | CN¥93.15 Million | ▼ -66.1% |
| 2018 | 8.36x | CN¥306.52 Million | CN¥36.66 Million | CN¥261.12 Million | ▲ +13.8% |
| 2017 | 7.35x | CN¥488.17 Million | CN¥66.42 Million | CN¥442.77 Million | ▲ +33.9% |
| 2016 | 5.49x | CN¥312.40 Million | CN¥56.90 Million | CN¥267.00 Million | ▲ +261.7% |
| 2015 | 1.52x | CN¥97.32 Million | CN¥64.11 Million | CN¥51.92 Million | ▲ +194.3% |
| 2014 | 0.52x | CN¥48.36 Million | CN¥93.75 Million | CN¥48.36 Million | ▼ -98.2% |
| 2011 | 28.82x | CN¥69.92 Million | CN¥2.43 Million | CN¥69.92 Million | ▲ +7308.6% |
| 2010 | 0.39x | CN¥21.86 Million | CN¥56.18 Million | CN¥21.86 Million | ▼ -94.2% |
| 2009 | 6.72x | CN¥23.27 Million | CN¥3.46 Million | CN¥23.27 Million | ▼ -36.7% |
| 2008 | 10.60x | CN¥6.39 Million | CN¥602.56K | CN¥6.39 Million | ▲ +941.2% |
| 2007 | 1.02x | CN¥107.55 Million | CN¥105.61 Million | CN¥107.55 Million | — |